For example, treatment with AXL inhibitor S49076 markedly decreased tumor resistance to bevacizumab, a VEGF/VEGFR blocker, in a colon carcinoma xenograft model and attenuated colony formation of FGFR1/2- and AXL-positive hepatocarcinoma cells (61). This evidence concerns the gene AXL and colon carcinoma.